Boston Trust Walden Corp Sells 6,372 Shares of Plexus Corp. $PLXS

Boston Trust Walden Corp reduced its stake in shares of Plexus Corp. (NASDAQ:PLXS) by 1.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 363,041 shares of the technology company’s stock after selling 6,372 shares during the period. Boston Trust Walden Corp owned 1.35% of Plexus worth $52,528,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in PLXS. Millennium Management LLC increased its holdings in shares of Plexus by 85.1% during the 1st quarter. Millennium Management LLC now owns 228,116 shares of the technology company’s stock valued at $29,229,000 after acquiring an additional 104,904 shares during the last quarter. American Century Companies Inc. boosted its position in Plexus by 12.9% during the second quarter. American Century Companies Inc. now owns 765,773 shares of the technology company’s stock worth $103,617,000 after purchasing an additional 87,551 shares during the period. Alyeska Investment Group L.P. acquired a new position in Plexus during the first quarter valued at approximately $10,458,000. Qube Research & Technologies Ltd raised its position in shares of Plexus by 37.1% in the second quarter. Qube Research & Technologies Ltd now owns 242,726 shares of the technology company’s stock valued at $32,843,000 after purchasing an additional 65,644 shares during the period. Finally, Bank of America Corp DE raised its position in shares of Plexus by 53.6% in the second quarter. Bank of America Corp DE now owns 177,237 shares of the technology company’s stock valued at $23,982,000 after purchasing an additional 61,817 shares during the period. Institutional investors and hedge funds own 94.45% of the company’s stock.

Plexus Stock Down 1.9%

NASDAQ PLXS opened at $151.29 on Tuesday. Plexus Corp. has a twelve month low of $103.43 and a twelve month high of $172.89. The stock has a market cap of $4.05 billion, a PE ratio of 24.17 and a beta of 0.81. The firm has a 50-day simple moving average of $146.96 and a 200 day simple moving average of $140.16. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.77 and a current ratio of 1.58.

Plexus (NASDAQ:PLXS) last posted its quarterly earnings results on Wednesday, October 22nd. The technology company reported $2.14 EPS for the quarter, beating the consensus estimate of $1.84 by $0.30. Plexus had a return on equity of 12.77% and a net margin of 4.29%.The firm had revenue of $1.06 billion during the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter in the prior year, the firm posted $1.85 EPS. The company’s revenue for the quarter was up .7% on a year-over-year basis. Plexus has set its Q1 2026 guidance at 1.660-1.810 EPS. On average, research analysts forecast that Plexus Corp. will post 5.9 EPS for the current year.

Analyst Ratings Changes

A number of research analysts recently issued reports on PLXS shares. Weiss Ratings reiterated a “hold (c+)” rating on shares of Plexus in a research note on Wednesday, October 8th. Benchmark reaffirmed a “buy” rating and issued a $165.00 price target on shares of Plexus in a research report on Friday, October 24th. Wall Street Zen lowered Plexus from a “buy” rating to a “hold” rating in a research note on Saturday, November 22nd. Needham & Company LLC increased their target price on Plexus from $158.00 to $165.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Finally, Sidoti lowered Plexus from a “buy” rating to a “neutral” rating and set a $150.00 target price on the stock. in a report on Friday, October 24th. Two analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, Plexus currently has an average rating of “Hold” and an average target price of $159.00.

Insider Activity

In related news, Director Karen Marie Rapp sold 500 shares of the company’s stock in a transaction dated Friday, November 28th. The shares were sold at an average price of $143.47, for a total value of $71,735.00. Following the sale, the director owned 7,665 shares of the company’s stock, valued at $1,099,697.55. The trade was a 6.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO Patrick John Jermain sold 2,000 shares of the firm’s stock in a transaction dated Tuesday, November 11th. The stock was sold at an average price of $143.53, for a total transaction of $287,060.00. Following the transaction, the chief financial officer owned 16,961 shares of the company’s stock, valued at approximately $2,434,412.33. This represents a 10.55% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 13,172 shares of company stock valued at $1,883,740. 1.78% of the stock is owned by insiders.

About Plexus

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.